M. Y. Tek Et Al. , "The extracellular A beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer's disease-like cellular model," 41st FEBS Congress on Molecular and Systems Biology for a Better Life , vol.283, Kusadasi, Turkey, pp.321, 2016
Tek, M. Y. Et Al. 2016. The extracellular A beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer's disease-like cellular model. 41st FEBS Congress on Molecular and Systems Biology for a Better Life , (Kusadasi, Turkey), 321.
Tek, M. Y., Biberoglu, K., Onder, S., Akbulut, K. G., & Tacal, O., (2016). The extracellular A beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer's disease-like cellular model . 41st FEBS Congress on Molecular and Systems Biology for a Better Life (pp.321). Kusadasi, Turkey
Tek, M. Et Al. "The extracellular A beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer's disease-like cellular model," 41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 2016
Tek, M. Y. Et Al. "The extracellular A beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer's disease-like cellular model." 41st FEBS Congress on Molecular and Systems Biology for a Better Life , Kusadasi, Turkey, pp.321, 2016
Tek, M. Y. Et Al. (2016) . "The extracellular A beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer's disease-like cellular model." 41st FEBS Congress on Molecular and Systems Biology for a Better Life , Kusadasi, Turkey, p.321.
@conferencepaper{conferencepaper, author={M. Yuksel Tek Et Al. }, title={The extracellular A beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer's disease-like cellular model}, congress name={41st FEBS Congress on Molecular and Systems Biology for a Better Life}, city={Kusadasi}, country={Turkey}, year={2016}, pages={321} }